Stock Spotlight Archives - Page 108 of 393

MondayAug 01, 2022 1:54 pm

QualityStocksNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Scaling Solutions, Targeting Accretive Growth

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network (“LN”), is scaling solutions through the LN. “The company released its first node (US-West) in November 2021, alongside its platform-as-a-service (“PaaS”) offering, https://lqwd.tech. The current capacity of US-West is 6.06271656 BTC (606,271,656 sat/ US$118,154.83); it has over 100 active channels and connected nodes currently operational. Over the last 30 days, US-West has experienced an increase of 0.277324 BTC (+4.79%), an increase of six channels (+5.71%), and a median fee rate of 0.000003 sat. LQwD’s nodes currently operate across 17…

MondayAug 01, 2022 1:43 pm

QualityStocksNewsBreaks – Eat Well Investment Group Inc.’s (CSE: EWG) (OTC: EWGFF) Sapientia Committed to Becoming Industry Leader in Snack Market

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) recently finalized the payment of $840,000, the last installment fulfilling all outstanding obligations toward the acquisition of Sapientia Technology LLC. “According to the company’s management, completing this milestone allows Sapientia to further collaborate with other Eat Well portfolio companies to increase its margins and expand its product lines and flavors. Since its acquisition, Sapientia has remained committed to becoming an industry leader in the snack market. It has created and filed four foundational patents revolving around the ‘Protein Twist’ and crispy puff style snack, capitalizing on the initial success of the protein…

MondayAug 01, 2022 1:35 pm

QualityStocksNewsBreaks – Friendable Inc.’s (FDBL) 360-Degree Offering Enables Ultimate ‘Anti-Label’ Solution

Friendable (OTC: FDBL) released the Fan Pass Live artist platform in July 2020. “Fan Pass Live allows independent artists to perform for and interact with fans without label control or costs. In January 2022, Friendable completed the acquisition of Artist Republik and FeaturedX to create the ultimate ‘anti-label,’ 360-degree solution for independent artists… With Artist Republik, artists can distribute their music, keep 100% of the royalties, and keep the rights to the music they produce. Artists receive royalty payouts quarterly, accessible through their Distribution Dashboard on the app. Artists are also afforded the opportunity to distribute and grow via Spotify…

FridayJul 29, 2022 2:16 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Leveraging Strategic Developments to Bring Its FIVE EV Crossover to Market

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, recently reported the results of its solid-state polymer battery testing. According to a recent article that contains excerpts from a Benzinga Brief, “Testing results from BIC [Battery Innovation Center] show the solid-state polymer cell, rated at 300 Ah and 3.7 volts, tested at 343.28 Ah at 4.2 volts, exceeding expectations, and is in line with test tolerance from previous EV Grid test results. The data supports solid-state polymer battery cell technology that, when scaled to the vehicle pack level and at a 150-kilowatt hour equivalent, can deliver over 600 miles…

FridayJul 29, 2022 1:51 pm

QualityStocksNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Aggressively Developing, Expanding Supply Capabilities to Cater to Growing Demand

EverGen (TSX.V: EVGN) (OTCQB: EVGIF) develops, owns and operates projects that take organic waste and convert that into renewable energy in the form of renewable natural gas (“RNG). “[Canadian utilities, like FortisBC] offer 20-year contracted offtakes to companies like ours to supply them with green energy, which provides a certainty for our business. Our business is then going out and building facilities that will take organic waste and convert it into RNG,” a recent article quotes EverGen co-founder and CEO Chase Edgelow as saying. According to the article, “EverGen has sought to cater to the growing demand for renewable natural…

FridayJul 29, 2022 1:30 pm

QualityStocksNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Looking to Capitalize on Booming iGaming, Esports Markets

Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, intends to capitalize on the burgeoning iGaming market expected to reach $127 billion by 2025 from $76.8 billion in 2020, buoyed by growth in Europe, the U.S. and Asia. “Golden Matrix’s GM-X system and newly launched GMX-Ag platform are a gold standard for the iGaming market, delivering access to 10,000+ games from over 25 leading providers. More than 635 unique casino operations use Golden Matrix’s platform to serve more than 7 million registered users. The company made its entrance into the lucrative European markets…

FridayJul 29, 2022 12:25 pm

QualityStocksNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Growing Company Assets Amid Challenges to Markets

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) is reporting positive news amid challenges occasioned by inflationary pressures and shortages provoked by production problems and further exacerbated by the global COVID pandemic and now the war in Ukraine. “Eat Well’s portfolio includes protein alternative (non-meat) foods and natural baby food brands, and distribution agreements with Walmart, Whole Foods, Amazon and other companies,” a recent article reads. “Eat Well’s president and CEO Marc Aneed recently was interviewed by The Market Herald [Canada]’s reporters at The Power Play, discussing the company’s financial filings for Q1 2022, including the growth of its cash…

ThursdayJul 28, 2022 12:21 pm

QualityStocksNewsBreaks – QSAM Biosciences Inc. (QSAM) Targeting Significant Unmet Medical Need with CycloSam(R)

QSAM Biosciences (OTCQB: QSAM) is a company developing a new class of drugs called radiopharmaceuticals that deliver radiation therapy directly and specifically to cancer cells. The company’s lead drug candidate, CycloSam(R), is a clinical-stage bone-seeking radiopharmaceutical designed to deliver targeted radiation safely and precisely to tumors in the bone. “QSAM is leading the charge to evaluate a new treatment for bone cancer and other related, underserved diseases. The company’s pioneering efforts are evident as the first patient has completed treatment in the company’s clinical trial designed to study the effect of its proprietary radiopharmaceutical technology: CycloSam(R),” a recent article reads.…

ThursdayJul 28, 2022 12:08 pm

QualityStocksNewsBreaks – FuelPositive Corporation’s (TSX.V: NHHH) (OTCQB: NHHHF) Ammonia Production System Designed to Eliminate Supply Chain Dependence, Stabilize Prices

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) is driving the message that fossil fuels do not only damage the climate but also make the world economically vulnerable. This comes amid high fertilizer prices and the inherent presence and effects of climate change, factors threatening the rice production industry worldwide. “Carbon emissions are the leading cause of climate change and global warming issues worldwide. The company’s Hydrogen-Ammonia Synthesizer technology provides the means necessary to store green hydrogen as green ammonia that is completely carbon-free. The hydrogen can be removed when needed for use in fuel cells and other applications based on pure hydrogen…

ThursdayJul 28, 2022 11:57 am

QualityStocksNewsBreaks – Odyssey Health Inc. (ODYY) Dedicating Strategy Toward Acquisition, Creation of Lifesaving Medical Products

Odyssey Health (OTC: ODYY) continues to dedicate its operational strategy toward the acquisition and creation of lifesaving medical products. “Odyssey’s portfolio includes medical device candidates and pharmaceutical products in development that are responsive to conditions such as heart disease, foreign object-induced choking, neurodegenerative disorders, and brain concussion injuries. One drug product designed to treat mild traumatic injury within the first few minutes after an incident is advancing in a phase 1 clinical human trial following on preclinical lab animal tests that provided encouraging data, CEO Michael Redmond said in a June interview,” a recent article reads. “No U.S. Food and…

Site Search

Company Search

Category: Stock Spotlight